Telmisartan and irbesartan therapy in type 2 diabetic patients treated with rosiglitazone: effects on insulin-resistance, leptin and tumor necrosis factor-alpha. (Q51476071)
Jump to navigation
Jump to search
scientific article published in November 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Telmisartan and irbesartan therapy in type 2 diabetic patients treated with rosiglitazone: effects on insulin-resistance, leptin and tumor necrosis factor-alpha. |
scientific article published in November 2006 |
Statements
Telmisartan and irbesartan therapy in type 2 diabetic patients treated with rosiglitazone: effects on insulin-resistance, leptin and tumor necrosis factor-alpha. (English)
1 reference
1 reference
1 reference
1 reference
Sibilla A T Salvadeo
1 reference
Ilaria Ferrari
1 reference
Alessia Gravina
1 reference
Pietro D Ragonesi
1 reference
Leonardina Ciccarelli
1 reference
Mario N Piccinni
1 reference
Roberto Fogari
1 reference
Fabio Pricolo
1 reference
1 November 2006
1 reference
29
1 reference
11
1 reference
849-856
1 reference